Compare XBIO & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIO | CHNR |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1M | 4.6M |
| IPO Year | N/A | 1995 |
| Metric | XBIO | CHNR |
|---|---|---|
| Price | $2.43 | $3.91 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 25.0K | 17.7K |
| Earning Date | 11-13-2025 | 12-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,858,935.00 | N/A |
| Revenue This Year | $1.99 | N/A |
| Revenue Next Year | $20.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.30 | N/A |
| 52 Week Low | $1.90 | $3.16 |
| 52 Week High | $13.93 | $8.20 |
| Indicator | XBIO | CHNR |
|---|---|---|
| Relative Strength Index (RSI) | 57.78 | 50.76 |
| Support Level | $2.20 | $3.62 |
| Resistance Level | $2.31 | $5.70 |
| Average True Range (ATR) | 0.10 | 0.35 |
| MACD | 0.05 | 0.08 |
| Stochastic Oscillator | 90.63 | 20.70 |
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.